These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 19475497

  • 1. Characterization of the largest kindred with MEN2A due to a Cys609Ser RET mutation.
    Mian C, Barollo S, Zambonin L, Pennelli G, Bernante P, Pelizzo MR, Nacamulli D, Mantero F, Girelli ME, Opocher G.
    Fam Cancer; 2009; 8(4):379-82. PubMed ID: 19475497
    [Abstract] [Full Text] [Related]

  • 2. Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation.
    Milos IN, Frank-Raue K, Wohllk N, Maia AL, Pusiol E, Patocs A, Robledo M, Biarnes J, Barontini M, Links TP, de Groot JW, Dvorakova S, Peczkowska M, Rybicki LA, Sullivan M, Raue F, Zosin I, Eng C, Neumann HP.
    Endocr Relat Cancer; 2008 Dec; 15(4):1035-41. PubMed ID: 18794325
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. High penetrance of pheochromocytoma in multiple endocrine neoplasia 2 caused by germ line RET codon 634 mutation in Japanese patients.
    Imai T, Uchino S, Okamoto T, Suzuki S, Kosugi S, Kikumori T, Sakurai A, MEN Consortium of Japan.
    Eur J Endocrinol; 2013 May; 168(5):683-7. PubMed ID: 23416954
    [Abstract] [Full Text] [Related]

  • 8. [A comparison of clinical characteristics between 2 pedigrees of multiple endocrine neoplasia type 2A with different RET mutations].
    Weng Y, Xue SN, Zhang SL, Cheng H, Yan L.
    Zhonghua Nei Ke Za Zhi; 2018 Feb 01; 57(2):134-137. PubMed ID: 29397600
    [Abstract] [Full Text] [Related]

  • 9. A rare missense variant in RET exon 8 in a Portuguese family with atypical multiple endocrine neoplasia type 2A.
    Martins AF, Martins JM, do Vale S, Dias T, Silveira C, da Silva IR, Carmo-Fonseca M.
    Hormones (Athens); 2016 Jul 01; 15(3):435-440. PubMed ID: 27838608
    [Abstract] [Full Text] [Related]

  • 10. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
    Kinlaw WB, Scott SM, Maue RA, Memoli VA, Harris RD, Daniels GH, Porter DM, Belloni DR, Spooner ET, Ernesti MM, Noll WW.
    Clin Endocrinol (Oxf); 2005 Dec 01; 63(6):676-82. PubMed ID: 16343103
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [The clinical patterns and RET proto-oncogene in fifteen multiple endocrine neoplasia type 2A pedigrees].
    Zhou YL, Zhu SX, Li JJ, Liu JB, Yin M, Xiao BY, Yu CL, Wang LM, Gu LQ, Cui B, Ning G, Li XY, Zhao YJ.
    Zhonghua Nei Ke Za Zhi; 2007 Jun 01; 46(6):466-70. PubMed ID: 17663821
    [Abstract] [Full Text] [Related]

  • 13. The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo.
    Oliveira MN, Hemerly JP, Bastos AU, Tamanaha R, Latini FR, Camacho CP, Impellizzeri A, Maciel RM, Cerutti JM.
    Thyroid; 2011 Sep 01; 21(9):975-85. PubMed ID: 21834681
    [Abstract] [Full Text] [Related]

  • 14. RET proto-oncogene mutations affecting codon 790/791: A mild form of multiple endocrine neoplasia type 2A syndrome?
    Gimm O, Niederle BE, Weber T, Bockhorn M, Ukkat J, Brauckhoff M, Thanh PN, Frilling A, Klar E, Niederle B, Dralle H.
    Surgery; 2002 Dec 01; 132(6):952-9; discussion 959. PubMed ID: 12490841
    [Abstract] [Full Text] [Related]

  • 15. Familial medullary thyroid carcinoma: not a distinct entity? Genotype-phenotype correlation in a large family.
    Moers AM, Landsvater RM, Schaap C, Jansen-Schillhorn van Veen JM, de Valk IA, Blijham GH, Höppener JW, Vroom TM, van Amstel HK, Lips CJ.
    Am J Med; 1996 Dec 01; 101(6):635-41. PubMed ID: 9003111
    [Abstract] [Full Text] [Related]

  • 16. Multiple endocrine neoplasia type 2.
    Wohllk N, Schweizer H, Erlic Z, Schmid KW, Walz MK, Raue F, Neumann HP.
    Best Pract Res Clin Endocrinol Metab; 2010 Jun 01; 24(3):371-87. PubMed ID: 20833330
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pheochromocytoma as the first manifestation of MEN2A with RET mutation S891A: report of a case.
    Hibi Y, Ohye T, Ogawa K, Shimizu Y, Shibata M, Kagawa C, Mizuno Y, Uchino S, Kosugi S, Kurahashi H, Iwase K.
    Surg Today; 2014 Nov 01; 44(11):2195-200. PubMed ID: 24449023
    [Abstract] [Full Text] [Related]

  • 20. Patients with RET D631Y mutations most commonly present with pheochromocytoma and not medullary thyroid carcinoma.
    Elston MS, Meyer-Rochow GY, Holdaway I, Conaglen JV.
    Horm Metab Res; 2012 May 01; 44(5):339-42. PubMed ID: 22274720
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.